U.S. Preventive Services Task Force (USPSTF)-Related Articles, June 26, 2015

Meester RG, Doubeni CA, Lansdorp-Vogelaar I, et al. Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: a microsimulation model. JAMA 2015 Jun 16; 313(23):2349-58. [Cites USPSTF recommendations on screening for colorectal cancer (Ann Intern Med, 2008).] Select to access the abstract.

Caverly T. Selecting the best candidates for lung cancer screening. JAMA Intern Med 2015 Jun; 175(6):898-900. [Cites USPSTF recommendations on screening for lung cancer (Ann Intern Med, 2014).] Select to access the abstract.

Keller DL. Corrections regarding prostate-specific antigen editorial. JAMA Intern Med 2015 Jun; 175(6):1067-8. [Discusses USPSTF selection of members for prostate cancer screening panels.] Select to access the abstract.

Schneider D, Arenberg D. Competing mortality in cancer screening: a teachable moment. JAMA Intern Med 2015 Jun; 175(6):896-7. [Cites USPSTF recommendations on screening for lung cancer and associated comparative modeling study (Ann Intern Med, 2014).] Select to access the abstract.

Gooding HC, Rodday AM, Wong JB, et al. Application of pediatric and adult guidelines for treatment of lipid levels among US adolescents transitioning to young adulthood. JAMA Pediatr 2015 Jun; 169(6):569-74. [Notes that author Gillman MW is a member of the USPSTF.] Select to access the abstract.

Dietz WH, Baur LA, Hall K, et al. Management of obesity: improvement of health-care training and systems for prevention and care. Lancet 2015 Jun 20; 385(9986):2521-33. [Cites USPSTF recommendations on screening for obesity in children and adolescents and associated systematic review (Pediatrics, 2010).] Select to access the abstract.

Kruger R. WE-B-207-01: CT lung cancer screening and the medical physicist: Background, findings and participant dosimetry summary of the National Lung Screening Trial (NLST). Med Phys 2015 Jun; 42(6):3664. [Mentions the USPSTF’s use of NLST findings in its recommendations on screening for lung cancer.] Select to access the abstract.

Lee C. WE-B-207-02: CT lung cancer screening and the medical physicist: A dosimetry summary of CT participants in the National Lung Cancer Screening Trial (NLST). Med Phys 2015 Jun; 42(6):3664. [Mentions the USPSTF’s use of NLST findings in its recommendations on screening for lung cancer.] Select to access the abstract.

McNitt-Gray M. WE-D-207-03: CT protocols for screening and the ACR Designated Lung Screening Program. Med Phys 2015 Jun; 42(6):3671. [Mentions the USPSTF’s use of NLST findings in its recommendations on screening for lung cancer.] Select to access the abstract.